--> jQuery(window).scroll(function() { checkStick(); }); var mbannerid = '#div-gpt-ad-1563273235586-0'; var mfooterid = '#footermobilebanner'; var dfooterid = '#div-gpt-ad-1563274691467-0'; // Desktop sticky check function checkStick() { var launched = false; if (jQuery(window).height() > 500) { if (!jQuery('#dfp_stickyfooter').hasClass("closed")) { if (jQuery('#dfp_stickyfooter > div').length) { if (!jQuery('#dfp_stickyfooter > div').hasClass("cog-mb-sticky")) { var width = jQuery('#dfp_stickyfooter > div > iframe').width(); var height = jQuery('#dfp_stickyfooter > div > iframe').height(); if (parseInt(width) > 0) { launched = true; jQuery('#dfp_stickyfooter').attr('style', 'height: '+(height+30)+'px;').addClass('opened'); jQuery('#dfp_stickyfooter').append(''); jQuery('#dfp_stickyfooter > div').addClass('cog-mb-sticky floating footer'); jQuery('#dfp_stickyfooter > div').attr('style', 'position:absolute; bottom:0;'); jQuery('#dfp_stickyfooter svg.close').on('click', function() { jQuery(this).parent().removeClass('opened').addClass('closed'); }); } } } } } if (!launched) { // Ad not ready yet window.setTimeout(checkStick, 250); } } jQuery(document).ready(function() {checkStick();}); -->

This site is intended for health professionals only

Home > News > Editor's pick > Off-label scrip decisions should assess risks and benefits for asthmatic children

Published on 8 March 2007

Share this story:

RELATED ARTICLES

Off-label scrip decisions should assess risks and benefits for asthmatic children

teaser

Researchers investigating the prevalence of “off-label” anti-asthma prescriptions in relation to clinical symptoms of asthma control in children have concluded that such prescribing by GPs is increasing, and decisions should assess the risks and benefits.

A UK-wide database of structured asthma review consultations was used to investigate the prevalence of off-label prescriptions in relation to clinical symptoms of asthma control. Of the 17,163 children, 1,050 (6.1%) received an off-label prescription, 325 (1.9%) received drugs not licensed for their age group, and 767 (4.5%) received drugs at a higher than recommended dosage.

The researchers reported that compared to children receiving medications within the licensed indications or doses, those who received off-label prescriptions reported significantly more nighttime symptoms, daytime symptoms, symptoms during activity and increased use of daily short-acting beta-2 agonists.

British Journal of General Practice 2007;57:220-22

Most read

1

Oral vitamin A could become an alternative to isotretinoin for acne

2

Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan

3

Amino acids supplement reduces muscle wasting and improves gut function in critically ill

4

Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest

5

Launch of the new Hospital Pharmacy Europe Mobile App

Be in the know

Subscribe to Hospital Pharmacy Europe newsletter and magazine

Subscribe

Share this story:

RELATED ARTICLES

x